from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1994c/cmtR

LFCtreatmentdescriptionclass of inhibitor

-0.471

Amikacinug/mL Amikacintranslation

-0.364

Cap5-10ug/mL Capreomycintranslation

-0.340

Rox10-50 ug/mL Roxithromycintranslation

-0.482

SM2-5 ug/mL Streptomycintranslation

0.123

Tet5-10 ug/mL Tetracyclinetranslation

-0.928

Rif0.2-5ug/mL Rifampicintranscription

-0.391

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.734

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.199

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.066

CPZ10-50 ug/mL Chlorpromazinerespiration

0.726

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.276

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.507

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.358

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.655

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.495

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.009

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.033

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.638

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.236

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.257

KCN5-20 ug/mL Potassium cyaniderespiration

-0.292

NaN30.2-2 mM Sodium aziderespiration

-0.866

Nigericin50 uM Nigericinrespiration

1.124

TRC10-150 ug/mL Triclosanrespiration

1.139

TRZ10-25 ug/mL Thioridazinerespiration

0.854

Valinomycin0.5-10 uM Valinomycinrespiration

-1.688

ZnSO42 mM ZnSO4respiration

-0.340

menadione6-10 ug/mL Menadionerespiration

0.210

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.418

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.475

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.658

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.645

NRP_1Non-replicating persistence stage 1dosRassociated

-0.656

Amp0.2mg/mL AmpicillincellWall

-0.182

Cephalexin20-100 ug/mL CephalexincellWall

-0.646

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.046

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.754

EMB10-20 ug/mL EthambutolcellWall

-0.826

Eta12-40 ug/mL EthionamidecellWall

-1.068

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.353

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.795

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.673

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.078

BZA0.12 mg/mL BenzamidearomaticAmides

0.069

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.625

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.632

H2O24 mM hydrogen peroxideDNAdamaging

-0.776

Levo10 ug/mL LevofloxacinDNAdamaging

-0.355

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.242

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.635

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.438

UVUV-irradiationDNAdamaging

5.288

ARP41-4 ug/mL Antitubercular compound ARP4?

0.020

Antimycin12.5-50 ug/mL Antimycin A?

-0.910

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.171

PA_110-50 ug/mL Antitubercular compound PA-1?

0.061

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.303

PA8240.2-2 ug/mL PA-824?

-0.024

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.013

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.288

Verapamil50 uM Verapamil?

-0.659

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.909

methoxatin10-20 ug/mL Methoxatin?